NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER BRIDGEBIO PHARMA, INC.Non-Qualified Stock Option Agreement • November 20th, 2019 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
Pursuant to the BridgeBio Pharma, Inc. 2019 Inducement Equity Plan as amended through the date hereof (the “Plan”), BridgeBio Pharma, Inc. (the “Company”), hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. For the avoidance of doubt, this Stock Option is not issued under the Company’s 2019 Stock Option and Incentive Plan, as amended from time to time, and does not reduce the share reserve under such equity plan. This Stock Option has been granted as an inducement pursuant to Rule 5635(c)(4) of the Marketplace Rules of the Nasdaq Stock Market, Inc. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue
RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES UNDER THE BRIDGEBIO PHARMA, INC.Restricted Stock Unit Award Agreement • November 20th, 2019 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
Pursuant to the BridgeBio Pharma, Inc. 2019 Inducement Equity Plan as amended through the date hereof (the “Plan”), BridgeBio Pharma, Inc. (the “Company”), hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.001 per share (the “Stock”) of the Company. For the avoidance of doubt, the Award is not issued under the Company’s 2019 Stock Option and Incentive Plan, as amended from time to time, and does not reduce the share reserve under such equity plan. This Award is granted as an “employment inducement award” pursuant to the exemption provided by Rule 5635(c)(4) of the Marketplace Rules of the NASDAQ Stock Market, Inc.
RESTRICTED STOCK AWARD AGREEMENT UNDER THE BRIDGEBIO PHARMA, INC.Restricted Stock Award Agreement • November 20th, 2019 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
Pursuant to the BridgeBio Pharma, Inc. 2019 Inducement Equity Plan (the “Plan”) as amended through the date hereof, BridgeBio Pharma, Inc. (the “Company”) hereby grants a Restricted Stock Award (an “Award”) to the Grantee named above. Upon acceptance of this Award, the Grantee shall receive the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above, subject to the restrictions and conditions set forth herein and in the Plan. The Company acknowledges the receipt from the Grantee of consideration with respect to the par value of the Stock in the form of cash, past or future services rendered to the Company by the Grantee or such other form of consideration as is acceptable to the Administrator. For the avoidance of doubt, the Award is not issued under the Company’s 2019 Stock Option and Incentive Plan, as amended from time to time, and does not reduce the share reserve under such equity plan. This Award is granted as an “employment induc
